Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Page 1
Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease.
Baumrin E, Shin DB, Mitra N, Pidala J, El Jurdi N, Lee SJ, Loren AW, Gelfand JM. Baumrin E, et al. Among authors: loren aw. JAMA Dermatol. 2024 Apr 1;160(4):393-401. doi: 10.1001/jamadermatol.2023.6277. JAMA Dermatol. 2024. PMID: 38416506
CONCLUSIONS AND RELEVANCE: The results of this cohort study demonstrated that skin chronic GVHD was independently associated with long-term PRO impairment, with sclerotic and combination disease carrying the highest morbidity. ...
CONCLUSIONS AND RELEVANCE: The results of this cohort study demonstrated that skin chronic GVHD was independently associated with long-te …
Patient-Centered Care in the Management of Cancer During Pregnancy.
Sorouri K, Loren AW, Amant F, Partridge AH. Sorouri K, et al. Among authors: loren aw. Am Soc Clin Oncol Educ Book. 2023 May;43:e100037. doi: 10.1200/EDBK_100037. Am Soc Clin Oncol Educ Book. 2023. PMID: 37220323 Free article.
Postpartum, breastfeeding should be discussed, and the neonate should receive blood work to assess for acute toxicities with follow-up arranged for long-term monitoring....
Postpartum, breastfeeding should be discussed, and the neonate should receive blood work to assess for acute toxicities with follow-up arran …
Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations.
Baumrin E, Loren AW, Falk SJ, Mays JW, Cowen EW. Baumrin E, et al. Among authors: loren aw. J Am Acad Dermatol. 2024 Jan;90(1):1-16. doi: 10.1016/j.jaad.2022.12.024. Epub 2022 Dec 23. J Am Acad Dermatol. 2024. PMID: 36572065 Review.
Chronic graft-versus-host disease is a major complication of allogeneic hematopoietic cell transplantation and a leading cause of long-term morbidity, nonrelapse mortality, and impaired health-related quality of life. ...
Chronic graft-versus-host disease is a major complication of allogeneic hematopoietic cell transplantation and a leading cause of long-te …
Chronic graft-versus-host disease. Part II: Disease activity grading and therapeutic management.
Baumrin E, Loren AW, Falk SJ, Mays JW, Cowen EW. Baumrin E, et al. Among authors: loren aw. J Am Acad Dermatol. 2024 Jan;90(1):19-36. doi: 10.1016/j.jaad.2022.12.023. Epub 2022 Dec 23. J Am Acad Dermatol. 2024. PMID: 36572064 Review.
Chronic graft-versus-host disease (cGVHD) is a major complication of allogeneic hematopoietic cell transplantation and a leading cause of long-term morbidity, nonrelapse mortality, and impaired health-related quality of life. ...
Chronic graft-versus-host disease (cGVHD) is a major complication of allogeneic hematopoietic cell transplantation and a leading cause of lo …
Self-Efficacy for Symptom Management in Long-Term Adult Hematopoietic Stem Cell Survivors.
Farhadfar N, Weaver MT, Al-Mansour Z, Yi JC, Jim HSL, Loren AW, Majhail NS, Whalen V, Uberti J, Wingard JR, Lynch Kelly D, Syrjala KL. Farhadfar N, et al. Among authors: loren aw. Transplant Cell Ther. 2022 Sep;28(9):606.e1-606.e8. doi: 10.1016/j.jtct.2022.05.035. Epub 2022 May 31. Transplant Cell Ther. 2022. PMID: 35662590 Free PMC article. Clinical Trial.
The case for classical haematology: the impact of a name and the future of a field.
Al-Samkari H, Loren AW, Lee AI. Al-Samkari H, et al. Among authors: loren aw. Lancet Haematol. 2022 Jun;9(6):e455-e459. doi: 10.1016/S2352-3026(22)00096-5. Epub 2022 Apr 29. Lancet Haematol. 2022. PMID: 35500590 Review.
In this Viewpoint, we argue that use of the terms benign and non-malignant to describe this field dismisses patient suffering, dampens trainee interest, and diminishes the field as a whole. We propose more uniform adoption of the term classical haematology by organisations …
In this Viewpoint, we argue that use of the terms benign and non-malignant to describe this field dismisses patient suffering, dampens train …
Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.
Melenhorst JJ, Chen GM, Wang M, Porter DL, Chen C, Collins MA, Gao P, Bandyopadhyay S, Sun H, Zhao Z, Lundh S, Pruteanu-Malinici I, Nobles CL, Maji S, Frey NV, Gill SI, Loren AW, Tian L, Kulikovskaya I, Gupta M, Ambrose DE, Davis MM, Fraietta JA, Brogdon JL, Young RM, Chew A, Levine BL, Siegel DL, Alanio C, Wherry EJ, Bushman FD, Lacey SF, Tan K, June CH. Melenhorst JJ, et al. Among authors: loren aw. Nature. 2022 Feb;602(7897):503-509. doi: 10.1038/s41586-021-04390-6. Epub 2022 Feb 2. Nature. 2022. PMID: 35110735 Free PMC article.
The adoptive transfer of T lymphocytes reprogrammed to target tumour cells has demonstrated potential for treatment of various cancers(1-7). However, little is known about the long-term potential and clonal stability of the infused cells. Here we studied long-lasting CD19- …
The adoptive transfer of T lymphocytes reprogrammed to target tumour cells has demonstrated potential for treatment of various cancers(1-7). …
Driving Distance and Patient-Reported Outcomes in Hematopoietic Cell Transplantation Survivors.
Banerjee R, Yi JC, Majhail NS, Jim HSL, Uberti J, Whalen V, Loren AW, Syrjala KL. Banerjee R, et al. Among authors: loren aw. Biol Blood Marrow Transplant. 2020 Nov;26(11):2132-2138. doi: 10.1016/j.bbmt.2020.08.002. Epub 2020 Aug 8. Biol Blood Marrow Transplant. 2020. PMID: 32781287 Free PMC article.
In summary, we found no impact of driving distance on distress and physical function among HCT survivors. Our results have implications for how long-term follow-up care is delivered after HCT, with regard to the negligible impact of driving distances on PROs and also the r …
In summary, we found no impact of driving distance on distress and physical function among HCT survivors. Our results have implications for …
Age and gender differences in financial distress among hematopoietic cell transplant survivors.
Jones SMW, Yi JC, Jim HSL, Loren AW, Majhail NS, Uberti J, Whalen V, Leisenring WM, Flowers MED, Lee SJ, Syrjala KL. Jones SMW, et al. Among authors: loren aw. Support Care Cancer. 2020 Sep;28(9):4361-4371. doi: 10.1007/s00520-019-05291-1. Epub 2020 Jan 8. Support Care Cancer. 2020. PMID: 31916007 Free PMC article.
PURPOSE: Cancer has long-term financial consequences. Adolescent and young adult (AYA) and middle-aged cancer survivors may experience more financial toxicity than older adults. ...
PURPOSE: Cancer has long-term financial consequences. Adolescent and young adult (AYA) and middle-aged cancer survivors may experienc …
Overview of Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies.
Singh N, Loren AW. Singh N, et al. Among authors: loren aw. Clin Chest Med. 2017 Dec;38(4):575-593. doi: 10.1016/j.ccm.2017.07.001. Clin Chest Med. 2017. PMID: 29128011 Review.
Key decisions include patient selection, donor and graft source, conditioning regimen, and graft-versus-host disease (GVHD) prophylaxis. Transplant is risky; only one-third survive long term. Complications include relapse, GVHD, infection, and end-organ dysfunction. Expand …
Key decisions include patient selection, donor and graft source, conditioning regimen, and graft-versus-host disease (GVHD) prophylaxis. Tra …
14 results